Registration, housing and abstract submission will open Wednesday, June 12 at 9:00 am ET.
Leading experts in the field of alcoholic liver disease (ALD) research and therapy will explore multiple aspects of managing patients. The Improving Outcomes in Alcohol-associated Liver Disease Through Robust Basic and Translational Research meeting will bridge critical gaps in ALD diagnosis, management and clinical trial design. Speakers will present evidence-based knowledge on ALD’s potential triggers, the role of alcohol dependence in management, various stages of disease, gender differences, and potential biomarkers for diagnosis, disease severity and prognosis. The program will include practical guidance on ways to create effective multidisciplinary teams to manage ALD patients, where hepatologists, addiction specialists, social workers, nurses and a patient’s family members work together as a team.
At the conclusion of this activity, participants will be able to:
Continuing education will not be provided for this conference.
US residents: Please review the Real ID Act regarding boarding federally regulated commercial aircrafts. Depending on your state of residence, you may need to provide a second form of identification at the airport.
Breakfast is served at 7 am ET both days.
Requests for cancellations must be submitted in writing to email@example.com.
Cancellations received on or before September 3, 2019 will be eligible for a full refund.
Cancellations received between September 4 – September 17, 2019 will be subject to a $50.00 cancellation fee.
Cancellations received on or after September 18, 2019 are not eligible for a refund.